Brenda Schulman

Brenda Schulman

Brenda Schulman is a leading biochemist and structural biologist. She has substantially contributed to the characterization of ubiquitin-like proteins (UBLs). Her main interest is how ubiquitin-like proteins and ubiquitin are able to specifically modify certain...
Matthew Meyerson

Matthew Meyerson

Matthew Meyerson is Director of the Center for Cancer Genomics and a member of the Department of Medical Oncology at Dana-Farber Cancer Institute (DFCI); Professor of Genetics and Medicine at Harvard Medical School and an American Cancer Society Research Professor;...
Emma Lundberg

Emma Lundberg

Emma Lundberg is currently a Professor in Cell Biology Proteomics at KTH Royal Institute of Technology, Sweden, and Director of the Cell Atlas, of the Human Protein Atlas program. She will be joining Stanford University’s Bioengineering Department as an Associate...
Nevan Krogan

Nevan Krogan

Nevan Krogan is a leading molecular and systems biologist whose current research is focused on the generation and analysis of large-scale genetic and protein-protein interaction datasets in a variety of organisms, ranging from bacteria to mammalian cells, with the...
Lyn Jones

Lyn Jones

Lyn Jones is the Director of the Center for Protein Degradation at the Dana-Farber Cancer Institute. His research interests include the creation and application of chemistry-based technologies to advance therapeutic target identification and accelerate drug discovery....